• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cbfa1/RUNX2指导骨硬化症基因(SOST)的特异性表达。

Cbfa1/RUNX2 directs specific expression of the sclerosteosis gene (SOST).

作者信息

Sevetson Brad, Taylor Scott, Pan Yang

机构信息

Functional Genomics Department, Amgen Corp, Seattle, Washington 98101, USA.

出版信息

J Biol Chem. 2004 Apr 2;279(14):13849-58. doi: 10.1074/jbc.M306249200. Epub 2004 Jan 22.

DOI:10.1074/jbc.M306249200
PMID:14739291
Abstract

Loss-of-function mutations in the sclerosteosis gene (SOST) cause a rare sclerosing bone dysplasia characterized by skeletal overgrowth. Cbfa1/RUNX2 is a key transcriptional regulator of osteoblast function. Here we link these two pathways by demonstrating, via gel shift and transient transfection analyses, that Cbfa1 binding to the proximal SOST promoter contributes to differential SOST expression in two osteosarcoma cell lines. Additionally, an E-box binding motif in the 1.8-kb proximal SOST promoter appears to be functional in SAOS-2 cells, but does not account for SAOS-specific expression of SOST. The regulation of SOST expression by Cbfa1 suggests a potential role for the sclerosteosis gene in homeostatic regulation of osteoblast differentiation and function. Furthermore, the juxtaposition of Cbfa1, E-box, and C/EBP binding sites in the SOST proximal promoter bears an intriguing resemblance to the promoter for osteocalcin, another osteoblast-specific gene with a loss-of-function phenotype of bone overgrowth.

摘要

硬化性骨病基因(SOST)的功能丧失突变会导致一种罕见的硬化性骨发育异常,其特征为骨骼过度生长。Cbfa1/RUNX2是成骨细胞功能的关键转录调节因子。在此,我们通过凝胶迁移和瞬时转染分析证明,Cbfa1与SOST近端启动子的结合促成了两种骨肉瘤细胞系中SOST的差异表达,从而将这两条途径联系起来。此外,1.8 kb的SOST近端启动子中的一个E盒结合基序在SAOS-2细胞中似乎具有功能,但不能解释SOST在SAOS细胞中的特异性表达。Cbfa1对SOST表达的调节表明,硬化性骨病基因在成骨细胞分化和功能的稳态调节中可能发挥作用。此外,SOST近端启动子中Cbfa1、E盒和C/EBP结合位点的并列与骨钙素的启动子有着有趣的相似之处,骨钙素是另一种具有骨过度生长功能丧失表型的成骨细胞特异性基因。

相似文献

1
Cbfa1/RUNX2 directs specific expression of the sclerosteosis gene (SOST).Cbfa1/RUNX2指导骨硬化症基因(SOST)的特异性表达。
J Biol Chem. 2004 Apr 2;279(14):13849-58. doi: 10.1074/jbc.M306249200. Epub 2004 Jan 22.
2
Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7.骨形态发生蛋白-7对人Runx2/Cbfa1基因启动子的转录调控
Mol Cell Endocrinol. 2003 Jul 31;205(1-2):121-9. doi: 10.1016/s0303-7207(03)00151-5.
3
Sclerostin is a direct target of osteoblast-specific transcription factor osterix.骨硬化蛋白是成骨细胞特异性转录因子骨形成蛋白-2 的直接靶标。
Biochem Biophys Res Commun. 2010 Oct 1;400(4):684-8. doi: 10.1016/j.bbrc.2010.08.128. Epub 2010 Sep 8.
4
Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.在C2C12成肌细胞中,响应骨形态发生蛋白-2和转化生长因子β1时CBFA1的短暂上调与成肌表型的抑制同时发生,但不足以促成成骨细胞分化。
J Cell Biochem. 1999 Apr 1;73(1):114-25.
5
Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.鉴定C2C12细胞中响应骨形态发生蛋白-7时Runx2/Cbfa1活性的潜在调节因子。
Cells Tissues Organs. 2004;176(1-3):28-40. doi: 10.1159/000075025.
6
Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype.在成骨细胞表型发育过程中,两种主要的Runx2/Cbfa1 N端亚型对骨形态发生蛋白-2的差异调节。
Endocrinology. 2001 Sep;142(9):4026-39. doi: 10.1210/endo.142.9.8367.
7
Characterization of the upstream mouse Cbfa1/Runx2 promoter.上游小鼠Cbfa1/Runx2启动子的特性分析
J Cell Biochem. 2001;82(4):647-59. doi: 10.1002/jcb.1192.
8
Control of the SOST bone enhancer by PTH using MEF2 transcription factors.甲状旁腺激素通过MEF2转录因子对SOST骨增强子的调控。
J Bone Miner Res. 2007 Dec;22(12):1957-67. doi: 10.1359/jbmr.070804.
9
Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression.激活转录因子4与Runx2/Cbfa1之间的协同相互作用刺激成骨细胞特异性骨钙素基因的表达。
J Biol Chem. 2005 Sep 2;280(35):30689-96. doi: 10.1074/jbc.M500750200. Epub 2005 Jul 5.
10
Regulation of human cbfa1 gene transcription in osteoblasts by selective estrogen receptor modulators (SERMs).选择性雌激素受体调节剂(SERM)对成骨细胞中人类cbfa1基因转录的调控
Mol Cell Endocrinol. 2001 Oct 25;183(1-2):71-9. doi: 10.1016/s0303-7207(01)00594-9.

引用本文的文献

1
Promising potential effects of resveratrol on oral and dental health maintenance: a comprehensive review.白藜芦醇对口腔和牙齿健康维护的潜在作用:一项综述
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1367-1389. doi: 10.1007/s00210-024-03457-1. Epub 2024 Sep 21.
2
Only bioactive forms of PTH (n-oxPTH and Met18(ox)-PTH) inhibit synthesis of sclerostin - evidence from in vitro and human studies.只有生物活性形式的 PTH(n-端氧化 PTH 和 Met18(氧化)-PTH)可抑制骨硬化蛋白的合成——来自体外和人体研究的证据。
Pflugers Arch. 2024 Jun;476(6):889-899. doi: 10.1007/s00424-024-02928-x. Epub 2024 Feb 23.
3
Converging evidence from exome sequencing and common variants implicates target genes for osteoporosis.
外显子测序和常见变异的汇聚证据提示骨质疏松症的靶基因。
Nat Genet. 2023 Aug;55(8):1277-1287. doi: 10.1038/s41588-023-01444-5. Epub 2023 Aug 9.
4
The Role of Sclerostin in Bone Diseases.硬化蛋白在骨疾病中的作用。
J Clin Med. 2022 Feb 2;11(3):806. doi: 10.3390/jcm11030806.
5
Wnt Pathway Extracellular Components and Their Essential Roles in Bone Homeostasis.Wnt 通路细胞外成分及其在骨稳态中的重要作用。
Genes (Basel). 2022 Jan 13;13(1):138. doi: 10.3390/genes13010138.
6
Sclerostin and Its Involvement in the Pathogenesis of Idiopathic Scoliosis.硬化蛋白及其在特发性脊柱侧凸发病机制中的作用
J Clin Med. 2021 Nov 14;10(22):5286. doi: 10.3390/jcm10225286.
7
Bone remodelling patterns around orthodontic mini-implants migrating in bone: an experimental study in rat vertebrae.正畸微种植体在骨内迁移时周围骨改建模式:大鼠椎骨的实验研究。
Eur J Orthod. 2021 Dec 1;43(6):708-717. doi: 10.1093/ejo/cjab065.
8
PPARG in osteocytes controls sclerostin expression, bone mass, marrow adiposity and mediates TZD-induced bone loss.成骨细胞中的过氧化物酶体增殖物激活受体γ(PPARG)控制着骨钙素的表达、骨量、骨髓脂肪含量,并介导噻唑烷二酮类药物(TZD)引起的骨丢失。
Bone. 2021 Jun;147:115913. doi: 10.1016/j.bone.2021.115913. Epub 2021 Mar 16.
9
Osteoporosis Treatment with Anti-Sclerostin Antibodies-Mechanisms of Action and Clinical Application.抗硬化蛋白抗体治疗骨质疏松症——作用机制与临床应用
J Clin Med. 2021 Feb 16;10(4):787. doi: 10.3390/jcm10040787.
10
Plasma sclerostin levels are associated with nutritional status and insulin resistance but not hormonal disturbances in women with polycystic ovary syndrome.多囊卵巢综合征妇女的血浆硬骨素水平与营养状况和胰岛素抵抗相关,但与激素紊乱无关。
Arch Gynecol Obstet. 2020 Oct;302(4):1025-1031. doi: 10.1007/s00404-020-05656-6. Epub 2020 Jun 26.